Yahoo Web Search

Search results

    • Ozempic Patients Need an Off-Ramp

      The Atlantic· 4 days ago

      When patients start on the latest obesity drugs, they find that their food cravings drop away, and then the pounds do too. Within a year of stopping semaglutide—better known by its brand names ...

    • This Unpopular Dividend Stock Is a Buy

      This Unpopular Dividend Stock Is a Buy

      Motley Fool via Yahoo Finance· 3 days ago

      BMS is dealing with the loss of patent protection for its cancer medication...categories sport failure rates over 90%. BMS has successfully lowered its...